Brand · Capsule · Updated Nov 11, 2026
Vraylar 3 mg capsule price what pharmacies pay, and what you should
Is my price fair?
Check the price you were quoted
Type what the pharmacy asked for vraylar 3 mg capsule and see the markup over what they pay.
A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.
Vraylar 3 mg price history
What pharmacies pay for 30 capsules, weekly- Now
- $1,525.85
- 52-week low
- $1,455.77
- 52-week high
- $1,528.68
- A year ago
- $1,455.65
Why the price changed
| Effective | Before | After | Change | Reason |
|---|---|---|---|---|
| Oct 21, 2026 | $50.88 | $50.86 | No change | pharmacies' invoice prices changed (survey) |
| Sep 23, 2026 | $50.88 | $50.88 | No change | pharmacies' invoice prices changed (survey) |
| Aug 19, 2026 | $50.88 | $50.88 | No change | pharmacies' invoice prices changed (survey) |
| Jun 17, 2026 | $50.89 | $50.88 | No change | pharmacies' invoice prices changed (survey) |
| May 20, 2026 | $50.96 | $50.89 | -0.1% | pharmacies' invoice prices changed (survey) |
| Jan 2, 2026 | $48.53 | $50.96 | +5.0% | WAC Adjustment |
| Dec 17, 2025 | $48.53 | $48.53 | No change | pharmacies' invoice prices changed (survey) |
| Nov 19, 2025 | $48.52 | $48.53 | No change | pharmacies' invoice prices changed (survey) |
Prices per capsule. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.
What people paid for vraylar 3 mg capsule
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Medicare negotiated price
Medicare negotiated a maximum fair price of $770.00 for a 30-day supply of Vraylar, against a 2024 list price of $1,376.00. It takes effect on January 1, 2027.
What this means for patients
- The negotiated price is what Medicare Part D plans pay for the drug - not your price at the counter.
- What you pay depends on your plan's copay or coinsurance and where you are in the year. Coinsurance (a percentage) falls with the price; a flat copay may not change at all.
- Out-of-pocket costs for Part D drugs are capped each year ($2,100 in 2026), whatever the drug.
- If you don't have Medicare, the negotiated price doesn't apply to you - check the fair cash price above instead.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
1 company sell vraylar 3 mg capsule under 3 package codes (NDCs). Pharmacies pay the same per capsule whichever maker they buy from - the national average is set for the generic as a group.
| Maker | Package codes | Per unit |
|---|---|---|
| Allergan, Inc. | 61874-130-20 61874-130-30 | $50.86 |
All 3 package codes
1 older package code is still priced but no longer in the current FDA listing.
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Questions to ask your pharmacist
- "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
- "Is a 90-day supply cheaper per capsule?" Dispensing fees are charged per fill, so fewer fills often cost less.
- "Do you match other pharmacies or accept discount cards?" Many do, if you ask.
These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.
Other vraylar strengths and forms
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 0.5 mg capsule Brand | $50.77 | $1,523.03 / 30 capsules |
| 0.75 mg capsule Brand | $50.81 | $1,524.26 / 30 capsules |
| 1.5 mg capsule Brand | $50.83 | $1,524.97 / 30 capsules |
| 4.5 mg capsule Brand | $50.78 | $1,523.48 / 30 capsules |
| 6 mg capsule Brand | $50.76 | $1,522.89 / 30 capsules |
Official label & what changed
These highlights do not include all the information needed to use VRAYLAR safely and effectively. See full prescribing information for VRAYLAR. VRAYLAR® (cariprazine) capsules, for oral useInitial U.S. Approval: 2015
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS
Increased Mortality in Elderly Patients with Dementia-Related Psychosis
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. VRAYLAR is not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions (5.1)].
Suicidal Thoughts and Behaviors
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for the emergence of suicidal thoughts and behaviors [see Warnings and Precautions (5.2)].
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS
See full prescribing information for complete boxed warning.
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. VRAYLAR is not approved for the treatment of patients with dementia-related psychosis. (5.1)
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. (5.2)
Recent major changes (as listed on the label)
Indications and Usage (1) | 12/2025 |
Dosage and Administration (2.2, 2.3, 2.6) | 12/2025 |
Warnings and Precautions, Metabolic Changes (5.7) | 12/2025 |
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about vraylar 3 mg capsule
How much does vraylar 3 mg capsule cost without insurance?
Pharmacies pay about $1,525.85 for 30 capsules ($50.86 per capsule) as of November 11, 2026. A fair cash price is about $1,765.23: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $1,764.73 including shipping.
Is my price for vraylar 3 mg capsule fair?
Compare it with the fair cash price of $1,765.23 for 30 capsules. Up to about $2,206.54 is fair; above $3,530.46 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.
Is vraylar 3 mg capsule getting more expensive?
Over the last four weeks the price pharmacies pay held steady. Over a year it rose 4.8%. See the 52-week chart.
Who makes vraylar 3 mg capsule?
1 company: Allergan, Inc.. See every package code.
Is vraylar in shortage?
No shortage is reported right now. We check every day.
Has vraylar been recalled?
1 recall on record. Recalls name specific lots - check yours.
What is the Medicare negotiated price?
$770.00 for a 30-day supply of Vraylar from January 1, 2027 (list price $1,376.00). Your own cost depends on your Part D plan.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about vraylar 3 mg capsule
No comments yet. Questions, tips, what worked for you - start the conversation.